Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US-Reference-Cited by-同舟云学术

Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US

Published:2021-09-01 Issue:9 Volume:6 Page:1060
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Cannon Christopher P.¹²,de Lemos James A.³,Rosenson Robert S.⁴,Ballantyne Christie M.⁵⁶,Liu Yuyin²,Gao Qi²,Palagashvilli Tamara⁷,Alam Shushama⁷,Mues Katherine E.⁷,Bhatt Deepak L.⁸,Kosiborod Mikhail N.⁹¹⁰,Knickelbine Thomas¹¹,Augenbraun Charles¹¹,Talano James¹¹,Wahid Faisal¹¹,Suh David¹¹,Khant Ranchhod¹¹,Aslam Shamaila¹¹,Merryman Scott¹¹,Herrington David¹¹,Patel Philip¹¹,Fox Kenneth¹¹,Lamba Sumant¹¹,Brodie Steven¹¹,Sheth Neil¹¹,Sheikh Kahlid¹¹,Geltzer Allen¹¹,Lillestol Michael¹¹,Dave Kamlesh¹¹,Koch Stanley¹¹,Lupovitch Steven¹¹,Piniella Carlos¹¹,Allen Lawrence¹¹,Vohra Rakesh¹¹,Geller Steven¹¹,Amin Rohit¹¹,Michieli Charles¹¹,Levin Philip¹¹,Shammas Nicolas¹¹,Potler Andrew¹¹,Santos Vladimir¹¹,Revana Madaiah¹¹,Lader Ellis¹¹,Strobl David¹¹,Supple Megan¹¹,Korpas Denes¹¹,DeSantis Donna¹¹,Fuchs-Ertman Debra¹¹,Eid Wael¹¹,Calhoun Linda¹¹,Upadhyaya Narendra¹¹,Cotter Ryan¹¹,Maciejko James¹¹,Ziajka Paul¹¹,Smith William¹¹,Antezano Eduardo¹¹,O Donnell Philip¹¹,Sloan Lance¹¹,Wilson Vance¹¹,Janosik Denise¹¹,Kmetzo James¹¹,Gangi Sumana¹¹,Dharma Chrisette¹¹,Godkar Darshan¹¹,Nicol Philip¹¹,Hong Micheal¹¹,Popkin Catherine¹¹,Patel Rajesh¹¹,Vargas Abelardo¹¹,Patel Minesh¹¹,Desai Vikas¹¹,Ma Yunsheng¹¹,Block Robert¹¹,Hiotis Louis¹¹,Grossman Colby¹¹,Arif Ahmed¹¹,Baum Seth¹¹,Sotolongo Carlos¹¹,Jordan Rebecca¹¹,Thompson Paul¹¹,Napoli Mark¹¹,Davidson Robert¹¹,Durrence Hugh¹¹,Aspry Karen¹¹,Miller Randall¹¹,Headley David¹¹,Rothschild Richard¹¹,Little Raymond¹¹,Meisner Carl¹¹,Powell Richard¹¹,Moon Eliot¹¹,Aggarwal Kul¹¹,Turner Mark¹¹,Acosta Idalia¹¹,Schear Martin¹¹,Harris Robert¹¹,Lending Robert¹¹,Salacata Abraham¹¹,Kalen Vicki¹¹,Bird C David¹¹,Mbogua Caroline¹¹,Duardo-Guerra Yamirka¹¹,McMullen Deirdre¹¹,Aazami Hessam¹¹,Lovell Charles¹¹,Busch Robert¹¹,Janout Marek¹¹,Alwine Lawrence¹¹,Barbel Johnson Kim¹¹,Dziko Svjetlana¹¹,Larry John¹¹,Cherian Joseph¹¹,Allen Gregory¹¹,Vargas Faye¹¹,Zarich Stuart¹¹,Ropero-Cartier Armando¹¹,Samuel Milroy¹¹,Khurana Sandeep¹¹,Rodriguez Ables Lilia¹¹,Gonzalez Marisela¹¹,Nelson Gregston¹¹,de Leon Lester¹¹,Martinez Luis¹¹,Badar Francisco¹¹,Phiambolis Thomas¹¹,Jaffrani Naseem¹¹,Eck John¹¹,Nowlan Brett¹¹,Martin Trever¹¹,

Affiliation:

1. Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts

2. Baim Institute for Clinical Research, Boston, Massachusetts

3. Division of Cardiology, The University of Texas Southwestern Medical Center, Dallas

4. The Cardiometabolic Disorders Unit, Icahn School of Medicine at Mount Sinai, New York, New York

5. Department of Medicine, Baylor College of Medicine, Houston, Texas

6. Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, Texas

7. Amgen Inc, Thousand Oaks, California

8. Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts

9. St Luke’s Mid America Heart Institute, University of Missouri, Kansas City, Kansas City

10. The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia

11. for the GOULD Investigators

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Link

https://jamanetwork.com/journals/jamacardiology/articlepdf/2780713/jamacardiology_cannon_2021_oi_210038_1631046565.30632.pdf

Reference20 articles.

1. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.;Baigent;Lancet,2010

2. Ezetimibe added to statin therapy after acute coronary syndromes.;Cannon;N Engl J Med,2015

3. Evolocumab and clinical outcomes in patients with cardiovascular disease.;Sabatine;N Engl J Med,2017

4. Alirocumab and cardiovascular outcomes after acute coronary syndrome.;Schwartz;N Engl J Med,2018

5. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.;Cannon;N Engl J Med,2004

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex specific analysis of patients with and without reported statin intolerance referred to a specialized outpatient lipid clinic;Biology of Sex Differences;2024-09-02

2. Closing the gap between guidelines and clinical practice for managing dyslipidemia: where are we now?;Expert Review of Cardiovascular Therapy;2024-09

3. Obicetrapib—the Rebirth of CETP Inhibitors?;Current Atherosclerosis Reports;2024-08-16

4. Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications;American Journal of Cardiovascular Drugs;2024-08-13

5. Effects of Inclisiran in Patients With Atherosclerotic Cardiovascular Disease;Mayo Clinic Proceedings;2024-08